{"name":"Chrono Therapeutics, Inc.","slug":"chrono-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NicoDerm CQ Patch","genericName":"NicoDerm CQ Patch","slug":"nicoderm-cq-patch","indication":"Smoking cessation as an aid to quit smoking","status":"marketed"}]}],"pipeline":[{"name":"NicoDerm CQ Patch","genericName":"NicoDerm CQ Patch","slug":"nicoderm-cq-patch","phase":"marketed","mechanism":"NicoDerm CQ delivers nicotine transdermally to replace nicotine from cigarettes and reduce withdrawal symptoms during smoking cessation.","indications":["Smoking cessation as an aid to quit smoking"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNVTJZSVR3YXlsS3RKMXFpQW1acGhhNFJfd0YxU1djSWZSd3R0RlNBbHd6V2JrQjA0MzJJVHJXNV8tRTFCVnd1aEVnaXRYUTYzR2lOZDZlbUN5Y29VOWRwY3VCcmViMWFVM2FxR0I4ajFNWG9QMWZwQkxOelFrdEdQYW03ZGQwV0xfTlhVazI4RTZDa1BHcTQ5N3dyOFo5TTJlQm5hRnZn?oc=5","date":"2025-04-02","type":"pipeline","source":"The Pharma Letter","summary":"Inhibrx announces leadership changes as co-founder departs - The Pharma Letter","headline":"Inhibrx announces leadership changes as co-founder departs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPUmd1Q1FTQ2M0Ykx1UnF0YXdmczFYbnNka0FjUGxGZmlBLVEyWE90dDJvNk5WOEU0bTEza1BnQ1VTc3cweEZMam14Mm5EN1Fjc1ZJUjJ0OF85b083R0FDazZLc1pxbDVRa2k5V01KZm45YzIyRHBfaDl1UGtJcGlJeGpmZUM2OGVDeDhqV1pFeVlQWF9DbmtUTGtwRnJOcllt?oc=5","date":"2023-11-30","type":"pipeline","source":"Medical Device and Diagnostic industry","summary":"Chrono Therapeutics’s Wearable Device Aims to Help Smokers Quit - Medical Device and Diagnostic industry","headline":"Chrono Therapeutics’s Wearable Device Aims to Help Smokers Quit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNalgwQ05SS3FFb0FuQVI5VjZUSzBueGw2cGEwMWtQT2lJR1owQ0RJcUNJYXBaRWliYXViLWtfcEVmcThWemZRazltMUhvbkc5dElwR0JDTjZVMWRScWZ2QnB5eHJteGhPYTBwZThrcnRiZXQxS0YtWG5vN0RUSUFlQmlwNXVMbXBkdE1FQ2dKdlc?oc=5","date":"2022-10-25","type":"pipeline","source":"citybiz","summary":"Sagimet Biosciences Appoints David Happel As CEO - citybiz","headline":"Sagimet Biosciences Appoints David Happel As CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxNcHptd2tOV3FubnJQaTZkekt4a2RrSlhCSVBOVWt1ZzlyU2drV3NBY1pnTjVlU3VTcU0zZ1pJXzhmSE5jd1Z0bGtsdlpkUEs0REpobW44TTdhdXdzSVhQMHJwTTYyZE11TWJTcEdFODFfTkc1UVFhRk9ZWUlWR2pucWxBdHA2cFN3Ykt6czYtMEVuTldfNE5lYmx1YlpoXzRkVGRfTFg5U29CR2VSZzhMb3RRN01KRll1aWU2MGlYSDVYM0d4amN1U2pqMDRnb1ZBYVd2VWZjeDBLRW9Kb3gxOEVDTDRxWTZuRlc5WDJXZHpwSmdDTEhEN3BEQVJpcTdTcWw5REttbnoyeU43Y2wtbVE3NUpkdjZpZ1RidGFBR2oxNDZDNGJv?oc=5","date":"2022-10-24","type":"pipeline","source":"Business Wire","summary":"Sagimet Biosciences Announces Appointment of David Happel to Chief Executive Officer; Dr. George Kemble to Transition to Executive Chairman Role - Business Wire","headline":"Sagimet Biosciences Announces Appointment of David Happel to Chief Executive Officer; Dr. George Kemble to Transition to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOaFV5UVBOaGtqX3BsWGdkdXl5ay1UZGZJMUFDS29hSVZDeHZxNlprQWV5S0NodjBfZ2k2SGg1dXBnbnhMdHF1SVZnQU9FVU9lMXE3RDk2UlpHMlNPc1NvRExfenBTNzZGQk1saWhkXzNobkp0akh3QTZTM0w4WnZqWk5WU3hQTWx3UDQtLU95T3RXUUxvWmUydk9CUDFCZGxudFl6ZlEwd3RycXVlZ3BvbnZPczZUWVR5WlVIMU91OHlETV9xdk02ZVc5XzdOZ0drV1VBRXNmVEFfampGNnlyWk9LT1Y4MUVvbkY1TFI3c2o2RzFVOFdn?oc=5","date":"2015-03-03","type":"pipeline","source":"PR Newswire","summary":"Chrono Therapeutics Receives Investment from Rock Health to Advance SmartStopTM Smoking Cessation Technology - PR Newswire","headline":"Chrono Therapeutics Receives Investment from Rock Health to Advance SmartStopTM Smoking Cessation Technology","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}